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Abstract.  Adult rat arterial smooth muscle cells are 
shown to express platelet-derived growth factor 
(PDGF) A  chain mRNA, to secrete a  PDGF-Iike mito- 
gen, and to bind exogenous PDGF in a phenotype- 
and growth state-dependent manner. In the intact aor- 
tic media, where the cells are in a  contractile pheno- 
type, only minute amounts of PDGF A  chain and no 
B chain (c-sis)  RNA were detected. After cultivation 
and modulation of the cells into a  synthetic phenotype, 
the A  chain gene was distinctly expressed,  whereas 
the B chain gene remained unexpressed.  Cells kept in 
serum-free medium on a  substrate of plasma fibronec- 
tin showed high levels of A  chain RNA and high 
PDGF receptor activity, but did not secrete detectable 
amounts of PDGF-like mitogen. After exposure to 
PDGF, which is itself sufficient to initiate DNA syn- 
thesis and mitosis in these cells, a  PDGF-Iike mitogen 
was released into the extracellular medium. Concomi- 
tantly, the amount of A  chain transcripts per cell and 
the ability of the cells to bind radioactive PDGF de- 
creased.  Similarly, smooth muscle cells initially grown 
in the presence of serum released more PDGF-like 
mitogen, contained fewer A  chain transcripts, and 
bound more radioactive PDGF in proliferating than in 
stationary cultures.  The findings confirm the notion 
that adult rat arterial smooth muscle cells are able to 
promote their own growth in an autocrine or paracrine 
manner. Furthermore, they reveal some basic princi- 
ples in the control of this process. 
p 
LATELET-derived growth  factor  (PDGF) ~ has  been 
recognized as a powerful mitogen for cells of mesen- 
chymal origin, such as arterial smooth muscle cells, 
fibroblasts, and glial cells. It is a cationic, 30-kD protein that 
binds to specific receptors on the surface of the responding 
cells and elicits a pleiotropic response that ultimately leads 
to DNA synthesis and mitosis (Heldin et al.,  1985; Ross et 
al., 1986). Structurally, PDGF is a dimer of two polypeptide 
chains linked by disulfide bonds. Two types of subunit chains 
have been identified, A and B, which can be combined into 
heterodimers or homodimers. The B chain is encoded by the 
protooncogene c-sis (Doolittle et al., 1983; Waterfield et al., 
1983) and the A chain by a gene locus that gives rise to a 
product with an overall  amino acid sequence homology of 
40% as compared with the B chain precursor (Betsholtz et 
al., 1986b). Several human tumor cell lines have been found 
to express  either or both of the PDGF-genes,  to produce 
PDGF-Iike proteins, and to promote their own growth in an 
1. Abbreviations used in this paper: medium F-12, Ham's medium F-12 sup- 
plemented with  10 mM Hepes/lO mM Tes (pH Z3), 50 I.tg/ml L-ascorbic 
acid, and 50 ~g gentamycin; NCS, newborn calf serum; PDGF, platelet- 
derived growth factor; SMC, smooth muscle cells. 
autocrine or paracrine  manner (Heldin and Westermark, 
1984; Betsholtz et al.,  1986b; Ross et al.,  1986). Evidence 
is accumulating to indicate that a  similar mechanism may 
also operate in normal cells during parts of their life cycles. 
Arterial smooth muscle cells (SMC) make up one exam- 
ple.  They form the media of the arterial wall and together 
with macrophages are the principal cells of atherosclerotic 
lesions (Ross,  1986; Schwartz et al.,  1986). Dependent on 
age,  the SMC appear  in at least two different phenotypic 
states. In the fetus and in the young evolving organism, they 
have a  fibroblast-like appearance,  divide, and secrete ex- 
tracellular matrix components; at this stage they are referred 
to as being in a synthetic phenotype. In the adult, the SMC 
become highly specialized muscle cells, which contract in 
response to chemical and mechanical stimuli and take part 
in the control of blood pressure and flow; at this stage they 
are referred to as being in a contractile phenotype (Chamley- 
Campbell et al., 1979; Schwartz et al., 1986). However, this 
change in differentiated characteristics with age is reversible. 
Thus, it is well established that SMC proliferation is an early 
key event in the formation of atherosclerotic lesions and that 
the SMC in the lesions are of a modified, fibroblast-like type 
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adult arterial SMC cultivated in vitro indicate that the cells 
normally go through a transition from a contractile to a syn- 
thetic phenotype before they become able to replicate (Fritz 
et al.,  1970; Chamley-Campbell et al., 1979, 1981; Thyberg 
et al.,  1983). 
This process includes a prominent reorganization of the 
cytoskeleton (Palmberg et al., 1985) with changes in the ex- 
pression ofactin (Gabbiani et al., 1984; Owens et al., 1986), 
myosin (Chamley et al., 1977; Larson et al., 1984), and inter- 
mediate filament proteins (Travo et al.,  1982; Skalli et al., 
1986). Concomitantly, the volume fraction occupied by myo- 
filaments is reduced and an extensive rough endoplasmic 
reticulum and a large Golgi complex are formed (Thyberg 
et al., 1983). As a result, the cells lose the ability to contract 
and start to secrete extracellular matrix components and di- 
vide (Burke and Ross, 1979; Chamley-Campbell et al., 1981; 
Thyberg et al.,  1983; Sj61und et al.,  1986). Furthermore, 
adult rat arterial SMC in primary culture express PDGF A 
chain mRNA (Sejersen et al., 1986) and produce a mitogen 
with  structural  and  immunological properties  similar  to 
PDGF, which may stimulate cell growth in an autocrine or 
paracrine manner (Nilsson et al., 1985). However, this func- 
tion appears transient and SMC from young rats were found 
to produce PDGF-like material in larger amounts and in a 
more stable way than cells from adult animals (Seifert et al., 
1984). Similarly, SMC isolated from intimal thickenings of 
injured rat arteries released more PDGF-Iike material than 
medial cells isolated from uninjured vessels (Walker et al., 
1986). 
Recent observations suggest that plasma fibronectin may 
be a major determinant of the phenotypic properties of adult 
arterial SMC (Hedin and Thyberg, 1987). When seeded on 
a substrate of this glycoprotein and cultured in a serum-free 
medium, the cells attached with high efficiency, and within 
3-4 d most of them modulated into a synthetic phenotype as 
resolved by electron microscopy. The structural transforma- 
tion was not itself accompanied by a proliferative response, 
but when exposed to PDGF or serum the cells promptly 
started to synthesize DNA and divide. This supports the no- 
tion that the change in phenotype is an absolute but not 
sufficient requirement for initiation of SMC growth (Cham- 
Icy-Campbell et al.,  1981; Thyberg et al.,  1983). Ongoing 
studies in our laboratory further indicate that the ability of 
fibronectin to promote the phenotypic modulation resides in 
the cell-binding domain of the molecule and that substrates 
of laminin and type IV collagen, two main constituents of the 
basal membrane that normally surrounds smooth muscle, re- 
tain the cells in a contractile phenotype (unpublished obser- 
vations). This suggests that the phenotypic modulation is a 
result of a specific receptor-ligand interaction, and not just 
a general adaptation to the in vitro environment. 
In the present investigation, we have studied the role of 
phenotypic properties and proliferative state in the control of 
PDGF gene expression and PDGF production by adult rat 
arterial SMC cultivated in vitro. The cells were used directly 
after isolation, kept in serum-free medium on a substrate of 
plasma fibronectin to allow modulation from a contractile to 
a synthetic phenotype, or kept on fibronectin and then ex- 
posed to PDGF to initiate DNA synthesis and mitosis. Alter- 
natively, the cells were grown in serum-containing medium 
and used in primary or secondary culture, either in a pro- 
liferating or in a nonproliferating state (for an overview of 
the main experimental groups, see Table I). RNA was iso- 
lated and examined for the presence of transcripts hybridiz- 
ing with cDNA probes for the PDGF A chain and B chain 
genes. Conditioned media were collected and assayed for 
mitogenic activity and content of material competing with 
authentic PDGF for binding to specific receptors on the sur- 
face of  human fibroblasts. The ability of  the SMC themselves 
to bind PDGF was also analyzed. Finally, we studied if the 
SMC are able to form colonies when grown in suspension 
in agar,  a  property normally associated with tumor cells 
(Shin et al.,  1975) and found to correlate with autocrine 
secretion of growth factors (Sporn and Todaro,  1980). Taken 
together, the results indicate that the SMC express PDGF A 
chain mRNA, secrete a PDGF-Iike mitogen, and bind exoge- 
nous PDGF  in a  phenotype- and growth state-dependent 
manner. 
Materials and Methods 
Cell Culture 
Ham's medium F-12 supplemented with 10 mM Hepes/10 mM Tes (pH 7.3), 
50 lxg/ml L-ascorbic acid, and 50 [.tg/ml gentamycin sulfate (medium F-12) 
was used. SMC were isolated from the aortic media of 4-5-mo-old mate 
Sprague-Dawley rats by digestion with 0.1%  collagenase (type I;  Sigma 
Chemical Co., St. Louis, MO) in medium F-12 with 0.1% BSA at 25~  first 
for 1 h to remove remaining endothelial cells and adventitiai fibroblasts and 
then for another 15-20 h to obtain complete dissolution of the tissue. Rou- 
tine examination  by  electron microscopy indicated that  this  procedure 
yielded a pure population of smooth muscle cells in a contractile phenotype 
(cf. Thyberg et al.,  1983).  The cells were seeded at 2  x  105 cells/cm  2 in 
Nunclon plastic petri dishes (Nunc, Roskilde, Denmark) in medium F-12 
with 0.1% BSA or 10% newborn calf serum (NCS) and the cultures were 
kept at 37~  in an atmosphere of 5% COs in air.  Medium was changed af- 
ter 1 d and thereafter every second day. To set up secondary cultures, the 
cells were detached by treatment with 0.25% trypsin (1:250; Difco Labora- 
tories, Inc., Detroit, MI) and 0.02%  EDTA in Ca  2+- and Mg2+-free PBS 
(pH 7.3). 
Culture  in  soft agar  was performed according to Benya and  Shaffer 
(1982). 60-ram plastic petri dishes (Lux; Flow Laboratories, Irvine, Scot- 
land) were coated with a bottom layer of 1% standard low relative molecular 
weight agarose (Bio-Rad Laboratories, Richmond, CA). Freshly isolated 
cells or cells obtained from confluent primary cultures by trypsinization 
were suspended in 0.5% low gel temperature agarose (Bio-Rad Laborato- 
ries) in medium F-12/10% NCS and 2 ml (3  x  105 cells) were poured into 
each dish. The dishes were kept at 37~  for 30 min to allow the cells to 
sediment and were then transferred to 4~  for 10 min to let the agar gel. 
The cultures were kept at 37~  in a humid chamber in an atmosphere of 
5% CO2 in air and medium was changed once a week, 
Isolation of  PDGF  and Fibronectin 
PDGF was isolated from fresh human platelets as described (Heldin et al., 
1987) and labeled with ~2~I to a specific activity of ~30,000 cpm/ng using 
the chloramine T method (Heldin et al., 1981b). Antibodies against PDGF 
were produced in rabbits (Heldin et al., 1981a) and irnmunoglobulins were 
purified from immune serum by chromatography on protein A-Sepharose 
(Pharmacia, Uppsala, Sweden). Fibronectin was purified from fresh-frozen 
human plasma by affinity chromatography on gelatin-Sepharose 4B (Phar- 
macia) as described (Ruoslahti et al., 1982; Hedin and Thyberg, 1987). To 
prepare cell culture substrates, fibronectin was dissolved in Dulbecco's PBS 
(PBS; pH 7.4) at 20 l~g]ml, poured into the petri dishes to cover the bottom, 
and left at 25~  for 60 min. The dishes were then rinsed twice with PBS 
and once with medium F-12/0.1% BSA before the seeding of cells. 
Collection of  Conditioned Media 
Cultures were rinsed four times with medium F-12 and then incubated with 
medium F-12/0.1% BSA for 48 h at 37~  Media were collected, centrifuged 
at 200 g for 10 rain, and used directly to assay PDGF receptor-competing 
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cells were detached by trypsinization and counted in a hemocytometer. Con- 
trol media were prepared from cell-free dishes in the same manner. 
RNA Isolation and Blot Analysis 
The cells were scraped off the petri dishes with a rubber policeman and 
RNA was isolated by extraction with hot phenol (Edmonds and Caramela, 
1969).  For intact aortas,  RNA was prepared using the LiCl/urea method 
(Auffrey and Rougeon, 1980). Samples of total cellular RNA (36 lag/lane) 
were fractionated by electrophoresis in agarose/formaidehyde (Lehrach et 
al., 1977) and transferred to nitrocellulose membranes (Thomas, 1980); the 
intactness of the RNA was verified in parallel gels stained with ethidium 
bromide (not shown). Hybridizations were done as described by Sejersen 
et al. (1985,  1986). eDNA probes were nick-translated in the presence of 
[32p]dCTP  (3,000  Ci/mmol) to  specific activities of "o4  ￿  108 @m/lag 
(Thomas,  1980).  The  following cloned  DNA  fragments  were  used  as 
probes: human PDGF A chain, clone D1 (Betsholtz et al., 1986b), and hu- 
man c-sis, clone pSM-1 (Clarke et al., 1984). The size of the transcripts was 
determined relative to rat  18S and 28S RNA. 
Assay of  PDGF Receptor-competing  Activity 
The ability of the conditioned media to compete with ~25I-PDGF for bind- 
ing to human foreskin fibroblasts (AG  1523) was measured as described 
(Nist6r et al.,  1984). Confluent fibroblast cultures were rinsed with PBS 
containing 0.1% BSA (binding medium) and exposed to conditioned media 
or varying amounts of PDGF (diluted in binding medium) for 150 min at 
4~  After rinsing with binding medium, the cells were exposed to  ~25I- 
PDGF (2 ng/ml) in binding medium for 45 min at 4~  They were then 
rinsed five times with binding medium and lysed in 1% Triton X-100/10% 
glycerol/20 mM Hepes (pH 7.4).  Finally,  radioactivity was determined in 
a gamma spectrometer. 
Assay of  PDGF  Receptor Binding 
SMC were grown in 12-well multidishes (4 cm2; Costar, Data Packaging 
Corp., Cambridge, MA). For the assay of PDGF receptor binding, the cul- 
tures were rinsed twice with binding medium (see above) and exposed to 
~25I-PDGF (4 ng/ml), with or without various amounts of unlabeled PDGE 
for 3 h at 4~  The cells were then rinsed and lysed as described in the 
preceding paragraph and cell-bound radioactivity was determined. Cell 
numbers were estimated in parallel cultures by trypsinization and counting 
in a hemocytometer. In an attempt to detect binding sites occupied by endog- 
enous or exogenous PDGE some cultures were incubated with 200 lag/ml 
of suramin (Bayer AG, Wuppertal, Federal Republic of Germany) in binding 
medium for 30 rain at 4~  before the exposure to 1251-PDGF; suramin has 
been shown to inhibit receptor binding of PDGF and to displace prebound 
PDGF (Williams et al.,  1984; Hosang,  1985). 
Assay of  DNA Synthesis 
Confluent primary cultures were trypsinized and secondary cultures were 
set up on glass coverslips in Nunclon 24-well multidishes (2 cm2; Nunc). 
The cells were grown to  subconfluence in  medium F-12/10%  NCS and 
growth arrested by incubation in medium F-12/0.1% BSA for 40 h.  They 
were  exposed to  experimental  media  in  the  presence of 2  I.tCi/ml  of 
[3H]thymidine  (5 Ci/mmol; Amersham International, Amersham, United 
Kingdom) for 24 h, rinsed, and fixed in 3% cacodylate-buffered glutaralde- 
hyde. After dehydration in ethanol, the coverslips were mounted on glass 
slides, dipped in NTB2 emulsion (Kodak Laboratory and Specialty Chemi- 
cals, Eastman Kodak Co., Rochester, NY), and air dried. The specimens 
were exposed at 4~  for 2 d, developed in D-19 (Kodak Laboratory and Spe- 
cialty Chemicals), and stained with methylene blue. To determine the label- 
ing index, at least 500 cells on each coverslip were counted. 
Electron Microscopy 
Primary fixation was done in 3 % glutaraldehyde in 0.1 M sodium cacodyl- 
ate-HCI buffer (pH 7.3)  with 50 mM sucrose. After postfixation in  1% 
osmium tetroxide in 0.1  M  cacodylate buffer (pH 7.3)  with 0.5%  potas- 
sium ferrocyanate for 60 min at 4~  the cells were dehydrated in ethanol, 
stained with 2% uranyl acetate in ethanol, and embedded in low viscosity 
epoxy  resin.  Thin  sections  were  cut  (Ultrotome  IV;  LKB,  Bromma, 
Sweden),  stained with alkaline  lead citrate,  and  examined in a  Philips 
EM 300. 
Results 
Expression of  PDGF Gene Activity 
Intact aortic tissue, freshly isolated SMC, and SMC grown 
in vitro under varying conditions were used to study the role 
of phenotypic properties and proliferative state in the control 
of PDGF gene expression (see Table I for further explanation 
of the experimental groups).  Because of problems  in ac- 
cumulating large numbers of SMC in primary and secondary 
culture (especially under serum-free conditions), no detailed 
kinetic analysis could be performed. RNA prepared from the 
intact, adult aortic media (dissected and predigested with 
collagenase to remove remaining endothelial cells and ad- 
ventitial fibroblasts) contained only small amounts of tran- 
scripts that hybridized with the cDNA probe for the PDGF 
A chain. Similarly, RNA prepared from freshly isolated cells 
(group I) reacted weakly with this probe. On the other hand, 
with one exception (group VII), all groups of cultivated cells 
(groups  II-VI)  showed an  increased content of PDGF  A 
chain transcripts (Fig. 1; Table II). There was a major band 
corresponding to a transcript of 1.7 kb. In a few groups there 
also appeared two minor bands, corresponding to transcripts 
of 1.3 and 2.3 kb, respectively (Fig. 1). A comparison of the 
relative strengths of the bands, as analyzed by scanning den- 
sitometry, and the RNA content of the cells, as analyzed by 
acridine orange staining and flow cytometry, indicated that 
the strongest expression of the PDGF A chain gene occurred 
in nonproliferating primary cultures (groups II and V; Table 
II). In contrast to these findings, no signs of expression of 
the PDGF B chain gene (c-sis) were detected, neither in the 
intact,  adult aortic media nor in any of the experimental 
groups (Table I). In this context it should be stressed that the 
Table L Main Experimental Groups of Smooth Muscle Cells 
Group  Culture  conditions  Functional  state of cells 
I 
II 
III 
IV 
V 
VI 
VII 
Freshly isolated cells 
Cells seeded on fibronectin and cultured in serum-free medium for 4  d 
Cells seeded on fibronectin, cultured in serum-free medium for 3 d, 
and then exposed to PDGF (20 ng/ml) for 24 h 
Primary cultures grown in serum-containing medium for 4-5  d 
Primary cultures grown in serum-containing medium for  12-14 d 
Secondary cultures grown in serum-containing medium for 4-5  d 
Secondary cultures grown in serum-containing medium for  12-14 d 
Contractile phenotype 
Synthetic phenotype, nonproliferating (subconfluent) 
Synthetic phenotype, proliferating (subconfluent) 
Synthetic phenotype, proliferating (subconfluent) 
Synthetic phenotype, nonproliferating (confluent) 
Synthetic phenotype, proliferating (subconfluent) 
Synthetic phenotype, nonproliferating (confluent) 
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RNA was isolated by phenol extraction, fractionated by electropho- 
resis in agarose/formaldehyde, and transferred to a nitrocellulose 
membrane. PDGF A chain transcripts were visualized by hybrid- 
ization to a 32P-labeled eDNA probe followed by autoradiography. 
A further description of the experimental groups is given in Table 
I. A, intact aorta. Sizes are shown in kilobases. 
rat genome has previously been shown to contain DNA se- 
quences that hybridize with the human cDNA probe used 
here (Sejersen et al.,  1986). 
Analysis of RNA samples from proliferating primary and 
secondary  cultures  of  arterial  SMC  from  10-d-old  rats 
showed that these cells expressed the PDGF A  chain gene 
(Fig. 2). The sizes of the transcripts were the same as in the 
adult ceils, but the relative amount of transcripts per unit to- 
tal RNA was markedly higher (5-10-fold) in secondary than 
in primary cultures (Fig. 2). Like the situation in the adult 
cells,  no  signs  of expression of the  PDGF B  chain gene 
(c-sis) were detected. 
Production of  a PDGF-like Mitogen 
To look for secretion of growth factors by the SMC, condi- 
tioned serum-free media were prepared (48 h) and tested for 
their ability to initiate DNA synthesis in serum-starved sec- 
ondary SMC cultures. Stimulatory material occurred in the 
media from all proliferating cultures (groups III, IV,  VI), 
Figure 2. RNA blot analysis of 
samples  from  newborn  rat 
arterial SMC. RNA was iso- 
lated  by  phenol  extraction, 
fractionated by electrophore- 
sis  in  agarose/formaldehyde, 
and transferred to a nitrocel- 
lulose  membrane.  PDGF  A 
chain transcripts were visual- 
ized by hybridization to a 32p. 
labeled eDNA probe followed 
by autoradiography. For com- 
parison, a sample from a con- 
fuent primary culture of  adult 
cells was run next to the sam- 
pies  from  subconfluent  pri- 
mary and secondary cultures 
of newborn  cells.  Sizes are 
shown in kilobases. 
and more so in primary than in secondary cultures (Fig. 3; 
see also Table IV). Media from confluent, nonproliferating 
primary  cultures  (group  V)  likewise  produced  a  distinct 
effect, with a labeling index about half of that given by op- 
timal  concentrations of PDGF  (10-20  ng/ml).  Antibodies 
against PDGF (50 ltg/ml) partially neutralized stimulatory 
effects in all groups (Fig.  3). 
An  important question  related  to  these  experiments  is 
whether or not PDGF and other serum growth factors may 
attach to the bottom of the plastic dishes or the fibronectin 
substrate during the early phases of culture and then detach 
during the conditioning. To test this possibility, conditioned 
media were prepared from cell-free dishes  and  tested for 
DNA synthesis-stimulating activity as described above. The 
results of this control experiment disclosed that no function- 
ally significant release of preadsorbed mitogens from the 
dishes  occurred during  the  conditioning  period  (Fig.  4). 
Moreover, it has previously been shown that pretreatment 
with actinomycin D inhibits the secretion of PDGF-like ma- 
terial by the SMC, indicating that this is a metabolically ac- 
tive process (Nilsson et al.,  1985). 
Table II. Expression of  PDGF A Chain mRNA in Smooth Muscle Cells* 
Experimental groups~: 
Group  Culture conditions 
Relative amount 
of A chain RNA 
per unit total RNAw 
Relative amount 
of total RNA 
per cell[I 
Relative amount 
of A chain RNA 
per cell 
I  Freshly isolated cells  1 
II  Fibronectin 4  d  9 
llI  Fibronectin 4  d,  PDGF final 24 h  4 
IV  Primary cultures/serum subconfluent  3 
V  Primary cultures/serum confluent  20 
VI  Secondary cultures/serum subconfluent  4 
VII  Secondary cultures/serum confluent  0 
1  1 
3  27 
3  12 
5  15 
6  120 
51  20 
6  ~1  0 
* Results of one experiment are shown (repeated once with similar results). 
For further details,  see Table I. 
w  Autoradiograms of RNA blots were scanned in a densitometer and the areas under the peaks were calculated.  Group I was set equal to 1. 
LI Cells were stained with acridine orange and analyzed for relative content of RNA in a fluorescence-activated cell sorter (Traganos et al.,  1977). Group I was 
set to equal to 1. 
1 Not determined,  presumed to be approximately the  same as in the primary cultures, 
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adult  rat arterial  SMC. Serum-free  conditioned  media were pre- 
pared and tested for their ability to initiate DNA synthesis in serum- 
starved secondary SMC cultures (left). The cells were exposed to 
PH]thymidine for 24 h in conditioned media without (open bars) 
or with (stippled  bars) 50 I~g/ml  of  PDGF antibodies (immunoglob- 
ulin fraction) and processed for autoradiography. Medium without 
or with addition of increasing amounts of PDGF served as controls 
(solidbar in left, and right). The results are given as means of  tripli- 
cate cultures. No adjustments for differences in cell numbers in the 
respective cultures were made (cf. Table IV). The experiment was 
repeated once with similar results. 
PDGF Receptor-competing Activity 
As a further test of the nature of the mitogen released by the 
SMC, conditioned media were examined in a radioreceptor 
assay.  Human fibroblasts were exposed to the conditioned 
media or varying amounts of pure, unlabeled PDGF at 4~ 
and were then allowed to bind  L25I-PDGF at 4~  In good 
agreement with  the  results  of the  DNA  synthesis  experi- 
ments, the cells in groups III-VI  were found to have released 
material that  competed with  ~25I-PDGF for binding  to  re- 
ceptors on the fibroblast surface (Table III). On a  per cell 
basis, the largest amounts of such material occurred in the 
conditioned media of primary cultures that had been kept on 
a  substrate of plasma fibronectin for 4  d  and had been ex- 
posed to PDGF for the final 24 h (group HI) and of primary 
and secondary cultures that had been grown in the presence 
of 10% serum for 4-5 d (groups IV and VI), i.e., in all cases 
cells that were in a subconfluent and proliferating state at the 
start of conditioning. 
PDGF Receptor Expression 
To analyze the ability of the SMC themselves to interact with 
PDGE receptor-binding experiments with  ~25I-PDGF were 
performed. These studies were restricted to the primary cul- 
tures (groups II-V), in which the strongest expression of the 
PDGF A chain gene and the most active release of a PDGF- 
like mitogen into the extracellular medium occurred.  The 
highest specific binding was found in group II, i.e., cells kept 
on a substrate of plasma fibronectin for 4  d and at no time 
exposed to exogenous mitogen.  In the other three groups, 
cells kept on fibronectin for 4  d  and exposed to PDGF for 
Figure 4. Lack of attachment and deattachment of PDGF to the cell 
culture substrates. Cell-free plastic petri dishes without and with 
(FN) a substrate of plasma fibronectin were prepared and exposed 
to medium F-12 with 0.1% BSA, 10% NCS, or 20 ng/ml of PDGF 
for 24 h at 37~  The dishes were then rinsed four times and in- 
cubated with medium  F-12/0.1% BSA for 48 h at 37~  Serum- 
starved secondary  SMC cultures  were exposed to [3H]thymidine 
in the conditioned media for 24 h and processed for autoradiogra- 
phy (open bars). Cultures  exposed to pH]thymidine  in medium 
F-12 with 10% NCS or 20 ng/ml of PDGF served as positive con- 
trois (stippled bars). The results are given as means of quadrupli- 
cate cultures. 
the  final  24  h  (group  III),  subconfluent primary cultures 
(group IV), and confluent primary cultures (group V), the 
specific binding was lower (Fig. 5 A). Preincubation of the 
cells with suramin lacked effect on the binding of t25I-PDGF 
in group II, whereas the binding increased in groups HI-V 
(Fig.  5 A). If the cells were first transferred to serum- and 
PDGF-free medium for 48 h  (corresponding to the condi- 
tioning period described above), the subsequent binding of 
Table III. Production of  PDGF Receptor-competing 
Activity by Smooth Muscle Cells* 
Experimental groupsw 
Group  Culture conditions  PDGF equivalents 
ng/ml/lO 6 cells 
II  Fibronectin 4  d  0.0 
HI  Fibronectin 4  d,  PDGF 
final 24 h  4.9 
IV  Primary cultures/serum 
subconfluent  11.4 
V  Primary cultures/serum 
confluent  0.3 
VI  Secondary cultures/sea'um 
subconfluent  4.0 
VH  Secondary cultures/serum 
confluent  0.1 
Conditioned media (48 h) were prepared and analyzed for content of PDGF- 
like material using a radioreceptor assay. Pure unlabeled PDGF was used to 
construct a standard curve and convert the receptor-competing activity of the 
samples into PDGF equivalents (ng/ml). 
* Results of one experiment are shown (repeated  twice with similar results). 
~: For further details, see Table I. 
Sj61und et al.  PDGF Secretion by Arterial Smooth Muscle Cells  407 Table IV. Summary of  Data on Expression of  PDGF A Chain mRNA, Secretion of  a PDGF-like  Mitogen, and PDGF 
Receptor Activity in Rat Arterial Smooth Muscle Cells* 
Experimental groupsr 
A Chain RNA  PDGF receptor  Mitogenic 
Group  Culture conditions  per cell  competing activityw  activityw 
PDGF receptor 
activityll 
I  Freshly isolated cells  +  ND  ND 
II  Fibronectin 4  d  + +  -  - 
III  Fibronectin 4  d, PDGF 
final 24 h  +  + +  + + 
IV  Primary cultures/serum 
subconfluent  +  + + +  + + + 
V  Primary cultures/serum 
confluent  + + +  +  + + 
VI  Secondary cultures/serum 
subconfluent  + +  + +  + 
VII  Secondary cultures/serum 
confluent  -  +  - 
ND 
+++/+++ 
+/++ 
+/++ 
+/++ 
ND 
ND 
* Based on the results in Table II, Table III, Fig. 3, and Fig. 5 (values transferred into a relative scale). 
~t For further details, see Table 1. 
w  On a per cell basis. 
II Without and with preincubation with suramin. 
12sI-PDGF  increased  in  all  groups.  However,  the  relative 
differences between the groups and the effects of preincuba- 
tion with suramin remained essentially the same (Fig. 5 B). 
To ascertain that the differences in 125I-PDGF binding de- 
scribed above were due to differences in receptor number and 
not differences in binding affinity, a Scatchard plot analysis 
was made on the cells in groups II and III; these cells were 
grown on a  substrate of fibronectin in serum-free medium 
and showed a high and a low binding of 125I-PDGF, respec- 
tively (Fig. 5). In both groups half-maximal binding was ob- 
Figure 5. PDGF receptor expression  of  adult rat arterial SMC. Cells 
were set up in primary culture (groups II-V) and tested for their 
ability to bind t25I-PDGF at 4~  either directly (left) or after incu- 
bation in serum-free medium for an additional 48 h at 37~  (right). 
(Open  bars)  Cells  exposed to  125I-PDGF;  (stippled  bars)  cells 
treated with suramin and then exposed to  ~25I-PDGF; (solid bars) 
cells exposed to ~2sI-PDGF in the presence of a 250-fold excess of 
unlabeled PDGF. The results are given as means of triplicate cul- 
tures. The experiment was repeated twice with similar results. 
mined at  1.5-2  nM and maximal binding at 4-6 nM.  The 
binding  data  indicated  a  single  class  of receptors  in  both 
groups,  with  a  Kd of  1.9  nM  in  group II and  1.8  nM  in 
group III. 
Growth of Cells in Sofl Agar 
The power of tumor cells to grow in an anchorage-indepen- 
dent manner has been found to correlate to autocrine secre- 
160 
80 
Primary Culture 
o 
J 
Secondary  Culture  / 
/ 
I 
0  10  20 
Time(days) 
Figure 6. Colony formation during growth in agar. Freshly isolated 
adult rat arterial SMC (primary cultures)  and SMC obtained from 
confluent monolayer cultures (secondary cultures) were suspended 
in agar and grown in normal medium (circles),  medium with 50 
~tg/ml of PDGF antibodies (triangles),  or medium with 200 ~tg/ml 
of suramin (squares).  At the indicated times, the number of cell 
colonies (>tO cells) in 25 randomly selected grid squares (4 mm  2 
each) was counted. Each value is the mean of duplicate or triplicate 
cultures. 
The Journal of Cell Biology, Volume 106, 1988  408 tion of growth factors (Sporn and Todaro, 1980).  Since the 
SMC secrete PDGF, it was considered of interest to examine 
if they share the ability to grow in suspension and if agents 
that are supposed to neutralize extracellular PDGF interfere 
with this process. Both freshly isolated cells (primary cul- 
tures) and cells obtained from confluent petri dishes by tryp- 
sinization (secondary cultures) were found to grow in soft 
agar in medium containing 10% serum. In primary cultures, 
most of the colonies (>10 cells) appeared to be formed al- 
ready during the first week (Fig. 6). No further increase in 
the number of colonies was seen after that,  but they con- 
tinued to grow in size for at least 3 wk, reaching a maximal 
diameter of 100-150 l~m (Fig. 7). Electron microscopic stud- 
ies indicated that the cells were all in synthetic phenotype 
with  an  extensive  rough  endoplasmic  reticulum,  a  large 
Golgi complex, and few myofilament bundles (Fig.  8).  In 
secondary cultures, the colonies became more numerous but 
considerably smaller than in primary cultures, reaching a 
maximum number after 3 wk (Fig. 6). The colony-forming 
efficiency was 0.3-0.7% in primary cultures and 1.0-1.5%  in 
secondary cultures.  Antibodies against  PDGF (50  llg/ml) 
lacked clear effect both on the number and size of the colo- 
nies.  With  suramin  (200  I.tg/ml),  the number of colonies 
formed during the first week was less than half of that in the 
control cultures. After 3 wk, the number of colonies was in- 
stead distinctly raised (Fig. 6). Compared with the controls, 
they were similar in overall size but more irregular in shape. 
Discussion 
General Comments 
The results of this study show that adult rat arterial SMC cul- 
tivated in  vitro express PDGF A  chain mRNA,  secrete a 
PDGF-Iike mitogen, and bind exogenous PDGF in a pheno- 
type- and growth state-dependent manner (summarized in 
Table IV).  Together with  the  results  of previous  reports 
(Nilsson et al.,  1985; Sejersen et al.,  1986; Hedin and Thy- 
berg, 1987), they suggest that plasma fibronectin and PDGF 
play an important role in controlling the phenotypic proper- 
ties of the cells and act in concert to give them the ability 
to stimulate their own growth in an autocrine or paracrine 
manner. In the following discussion, we will briefly consider 
the role of age in this process. We will then discuss the obser- 
vations on the adult cell system in some detail and end by pre- 
senting a tentative model of autocrine growth regulation in 
arterial smooth muscle. 
On the Role of  Age in PDGF  Secretion  by Arterial SMC 
A  comparison of SMC  from adult and young animals re- 
vealed that both expressed PDGF A chain but not B chain 
(c-sis) mRNA. After transfer from primary to secondary cul- 
ture, the content of A  chain transcripts decreased in adult 
cells but increased in young cells. Accordingly, SMC from 
adult rats were found to release a PDGF-like mitogen into the 
medium only during a limited period in primary and second- 
ary culture, whereas young SMC have been observed to do 
so continually during a large number of passages (Seifert et 
al.,  1984). Taken together, these fndings suggest that secre- 
tion of PDGF is a constitutive function of arterial SMC in 
the young and growing organism. In the adult, this function 
is normally lost and can be resumed only after return of the 
Figure 7. Light microscopy of agar colonies. Freshly isolated adult 
rat arterial  SMC were suspended in agar and grown in normal 
medium for 3 wk. After fixation in 3 % buffered glutaraldehyde, the 
cultures were stained with 0.05  % methylene blue for 5 min. Bar, 
25 ~tm. 
cells to a phenotypic state similar to that in the young (see 
below). Such a  change in differentiated characteristics oc- 
curs as a consistent response to in vitro cultivation (Fritz et 
al.,  1970; Chamley-Campbell et al.,  1979; Thyberg et al., 
1983), possibly as a result of interaction with plasma fibro- 
nectin (Hedin and Thyberg, 1987). In vivo a similar change 
may be induced by endothelial damage and penetration of 
blood components into the underlying media (Schwartz et 
al.,  1986). 
PDGF  A Chain Gene Expression and PDGF  Secretion 
by Adult Arterial SMC Is a Phenotype- and Growth 
State-dependent Process 
Only minute amounts  of PDGF A  chain and  no B  chain 
(c-sis) transcripts were detected in RNA isolated from the in- 
tact aortic media. This is in good agreement with the notion 
that arterial SMC  are normally in  a  highly differentiated, 
contractile, and nonproliferative state (Chamley-Campbell et 
al.,  1979; Schwartz et al.,  1986).  In contrast, isolated and 
cultivated  SMC  distinctly  expressed  the  PDGF  A  chain 
gene, whereas the B chain (c-sis) gene remained silent.  A 
similar pattern of PDGF gene expression has been noted in 
several human tumor cell lines, but cell lines that express 
only the B chain gene or both the A and B chain genes have 
also been observed (Betsholtz et al.,  1986b). 
The discovery of  raised levels of  PDGF A chain transcripts 
in RNA from the newly isolated SMC (group I) was some- 
what surprising.  As judged by electron microscopy, these 
cells are in a contractile phenotype similar to that of the cells 
in the intact aortic media.  They have an extensive myofila- 
merit system, few free ribosomes, and a poorly developed 
rough endoplasmic reticulum (Thyberg et al., 1983). Hence, 
Sjblund et al. PDGF Secretion by Arterial Smooth Muscle Cells  409 Figure 8. Electron microscopy of agar colonies. Freshly isolated adult rat arterial SMC were suspended in agar, grown in normal medium 
for 5 wk, and fixed in 3% buffered glutaraldehyde. (A) Overview; (B) detail of a rounded, central cell. All the cells in the colonies are 
in synthetic phenotype with an extensive rough endoplasmic reticulum (RER) and a  large Golgi complex (G). L, lysosomes; LD, lipid 
droplet; M, mitochondria. Bars: (A) 5  ~tm; (B)  1 txrn. 
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fraction of the cells already during the collagenase digestion, 
perhaps as one of the first events in the phenotypic modula- 
tion. More direct evidence for a link between these processes 
was obtained by the observation that cells kept in serum-free 
medium on a substrate of plasma fibronectin for 4 d (group 
II) were among those that most strongly expressed the PDGF 
A chain gene. Previous studies have shown that these cells 
rapidly convert into synthetic phenotype, but do not start to 
proliferate without exogenous mitogen stimulation  (Hedin 
and Thyberg, 1987). Likewise, they were not found to release 
detectable amounts of PDGF-like material and showed a high 
PDGF receptor activity, without signs of receptor occupancy 
using the  suramin  displacement method (Williams  et al., 
1984; Hosang,  1985). 
If, on the other hand, the SMC were kept on a substrate 
of plasma fibronectin for 4 d and were exposed to PDGF for 
the final 24 h (group III), they started to discharge a PDGF- 
like agonist into the culture medium (conceivably a PDGF 
A chain homodimer). Therefore, it is concluded that at least 
two requirements need to be fulfilled before the cells are able 
to synthesize and secrete their own PDGE First, they must 
go through  a  transition  from a  contractile to  a  synthetic 
phenotype and,  second,  they have  to be  stimulated  with 
PDGF, or possibly some other mitogen. Although detailed 
experimental data are still lacking, the findings further sug- 
gest that the transcription of the PDGF A chain gene and the 
subsequent synthesis and processing of the protein are con- 
trolled separately. 
Concomitant with the secretion of a PDGF-like mitogen, 
the cellular content of PDGF A chain transcripts decreased. 
This suggests that the appearance of the gene product brings 
about a lowered rate of transcription of the gene or an in- 
creased rate  of degradation  of preexisting  transcripts,  or 
both.  The actively secretory cells also  showed a  reduced 
ability to bind PDGE evidently due to a reduced number of 
cell surface receptors as the binding constants did not differ 
(comparison between groups II and III).  Previous studies 
have indicated that after uptake by endocytosis, both PDGF 
and its receptor are normally transferred to lysosomes and 
broken down by acid hydrolases (Heldin et al., 1982; Nilsson 
et al.,  1983; Rosenfeld et al.,  1984).  Such a receptor down 
regulation could partly explain the decreased binding of the 
radioactive probe in cells exposed to PDGF (group III). Con- 
ceivably, PDGF produced by the cells themselves will like- 
wise induce a receptor degradation and contribute to the re- 
duced binding capacity. Moreover, part of the bound PDGF 
will remain on the cell surface for a considerable time and 
block some of the receptors (Heldin et al.,  1982; Nilsson et 
al., 1983). Accordingly, preincubation of the cells with sura- 
rain, which dissociates PDGF from its receptor (Williams et 
al.,  1984; Hosang,  1985),  increased the subsequent binding 
of the radioactive probe. It should also be noted that incuba- 
tion of the cells in PDGF-free medium for an additional 48 h 
before the binding experiment increased the PDGF receptor 
activity. This suggests that a  net renewal of receptors oc- 
curred in the absence of exogenous PDGE although produc- 
tion of a PDGF-like molecule by the cells themselves con- 
tinued (group III). 
A comparison of primary and secondary cultures kept in 
serum-containing medium and examined in different growth 
phases (group IV-VII) corroborated the above findings and 
provided additional information concerning the regulation of 
PDGF secretion in the SMC. In primary cultures, the release 
of PDGF*like material into the medium slowed down as the 
cells passed from a proliferating into a stationary phase, and 
in secondary cultures it seemed to stop completely (see Table 
IV). At the same time, the number of PDGF A chain tran- 
scripts per cell rose in primary cultures but dropped below 
the detection limit in secondary cultures. We interpret these 
findings to indicate that the ability of adult rat arterial SMC 
to produce PDGF during in vitro cultivation is transient and 
dependent on proliferative rate. It comes to a peak during the 
exponential growth phase early in primary culture and then 
declines as the cells become confluent. Nevertheless, PDGF 
mRNA is retained or synthesized de novo and as the cells are 
trypsinized, reseeded at lower density, and start again to di- 
vide, PDGF production is resumed, although now at a lower 
level. 
Adult Arterial SMC Are Able to Grow in an 
Anchorage-independent Way 
It is well established that tumor cells are able to grow in an 
anchorage-independent way  (Shin  et  al.,  1975). This  has 
been found to correlate with autocrine secretion of growth 
factors (Sporn and Todaro,  1980).  Accordingly, it was re- 
cently shown that human fibroblasts infected with  simian 
sarcoma virus not only produce a protein similar to PDGF 
but also form colonies in suspension in agar Oohnsson et al., 
1986).  Here it is demonstrated that adult rat arterial SMC 
share this property. Similarly, it has previously been demon- 
strated that bovine arterial SMC are able to grow in soft agar 
when stimulated with a  combination of PDGF, epidermal 
growth factor, and transforming growth factor [~ (Assoian 
and Sporn,  1986). 
Our findings further indicate that the SMC do not need to 
be attached to a substrate to go through the modulation from 
a contractile to a synthetic phenotype. Thus, all cells in the 
colonies were in a synthetic state with an extensive rough en- 
doplasmic reticulum, a large Golgi complex, and few myo- 
filament bundles. The colony-forming  efficiency  was lower in 
primary than in secondary cultures, probably due to loss of 
cells during the initial phenotypic modulation in the former. 
PDGF antibodies lacked inhibitory effect on the colony for- 
mation and, likewise, have been found to lack effect on the 
autocrine stimulation of the cells in monolayer culture (Nils- 
son et al., 1985). A possible reason could be that the antibod- 
ies, due to their size, are unable to penetrate into the pericel- 
lular environment and react with PDGF released locally. The 
antiparasital drug suramin, a smaller molecule that is known 
to inhibit receptor binding of PDGF as well as to displace 
prebound  PDGF  (Williams  et al.,  1984;  Hosang,  1985), 
slowed down colony formation during the first week of cul- 
ture. After another 2 wk, and of unknown reason, the num- 
ber of colonies was markedly higher in suramin-treated than 
in control cultures. In contrast to these findings, suramin was 
found to efficiently revert the transformed phenotype of hu- 
man and rat fibroblasts infected with simian sarcoma virus, 
but in this case the growth properties of the cells were exam- 
ined only in monolayer culture (Betsholtz et al.,  1986a). 
Tentative Model of  Autocrine Growth Regulation in 
Adult Arterial SMC 
Based on these and other recent findings  (Nilsson et al., 
1985; Sejersen et al.,  1986; Hedin and Thyberg, 1987), and 
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model of autocrine growth regulation in adult arterial  SMC 
is presented. This model includes the following main steps: 
(a) Upon contact with plasma fibronectin, the smooth mus- 
cle cells modulate from a contractile to a synthetic pheno- 
type. As parts of this process, PDGF receptors are expressed 
at the cell  surface and transcription of the PDGF A  chain 
gene  is  induced.  (b)  After  stimulation  with  exogenous 
PDGE  the cells synthesize DNA and divide.  Additionally, 
they start to produce PDGF (A chain homodimers).  These 
molecules bind to and activate PDGF receptors on the cell 
itself (autocrine stimulation) or, after diffusion through the 
extracellular medium, PDGF receptors of neighboring cells 
(paracrine  stimulation).  (c) In response to the synthesis of 
PDGE the transcription  of the PDGF A chain gene decreases. 
The fate of preexisting transcripts may vary, for example de- 
pending on the number of previous cell divisions. However, 
ultimately the transcripts will be degraded.  As a result, the 
synthesis of PDGF will terminate and the autocrine stimula- 
tion of the cells will cease. 
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